What is Biopharma 4.0? Biopharma 4.0 refers to the next-generation modernisation approach to biopharmaceutical development, manufacturing, and quality. It integrates advanced digital, automation, and data-driven technologies to maintain or enhance safety, quality, identity, potency, and purity (SQuIPP), while accelerating timelines across the therapeutic lifecycle, including research, development, and production. Inspired by the broader Industry 4.0 movement, it applies both digital tools and physical innovations to reshape how therapies are discovered, developed, and delivered.

This transformation allows biopharma organisations to improve efficiency, reduce costs, and uphold compliance, all while delivering high-quality products to patients more quickly. Adaptation to the principles of Biopharma 4.0 also enables platformability – the ability to establish standardised manufacturing unit operations and analytical methods to produce a specific therapeutic modality from a specific source to meet established specifications.